Topic: Animal Trials

A supercut of news anchors warns users to be "extra cautious" when looking for health information on Twitter following the platform's decision to drop its COVID-19 misinformation policy. In separate news, the FDA will no longer require animal testing before human drug trials, a move praised by animal rights groups but questioned by those concerned about human safety in early-stage pharmaceutical research.

An Associated Press fact check clarified that Pfizer and Moderna did not skip animal trials, but rather conducted them simultaneously with Phase 1 human trials. Dr. William Moss of Johns Hopkins University explained that preclinical studies on mice and macaques were overlapped with early human testing to accelerate development. The report disputes online claims that mRNA vaccines were never tested on animals due to inflammation risks.

The discussion touches on the bypassing of traditional animal trials for COVID-19 vaccines and the alleged suppression of Ivermectin as a treatment. The hosts suggest that the pharmaceutical industry actively discredits alternative treatments to protect the market for vaccines.

Doctors Andrew Kaufman, Hilde Smets, and Nils Voss argue that the COVID-19 vaccine is unsafe because animal trials were skipped. They claim previous attempts to develop coronavirus vaccines resulted in severe autoimmune disorders when animals were later exposed to wild-type viruses.

The hosts highlight a verbal slip by Anthony Fauci regarding vaccine recommendation for his family. They also discuss concerns from vaccine skeptics regarding the lack of long-term animal trials and the history of failed coronavirus vaccine attempts in the past.

Robert Kennedy Jr. raised concerns about "pathogenic priming" or enhanced immune response in coronavirus vaccine development. He cited historical animal trials where ferrets developed lethal inflammation after being exposed to wild viruses post-vaccination. Kennedy criticized Dr. Anthony Fauci for allowing manufacturers to skip long-term animal testing before proceeding to human trials.